TrialCancer science2017

Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.

Takashi Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.